mthfr and methyl b12 injections for autism Untitled Methylated B12 Liquid - MTHFR

Cagrilintide vs tirzepatide (Mounjaro/Zepbound) Mechanism: Cagrilintide: Amylin agonist Tirzepatide: Dual GIP/GLP-1 agonist Both novel approaches Weight loss: Cagrilintide: 10-12% monotherapy Tirzepatide: 15-22% monotherapy Tirzepatide superior as single agent Administration: Both: Weekly subcutaneous injection Both: Similar convenience Side effects: Cagrilintide: Strong GI effects Tirzepatide: Moderate GI effects Similar overall profile Approval status: Cagrilintide: Investigational Tirzepatide: FDA approved Tirzepatide available now Cost (when both available): Likely similar ($1,000-1,500/month) Both premium weight loss options Verdict: Currently, tirzepatide better choice (approved, superior weight loss)

[DOI] [PubMed] [Google Scholar] 25.Bhatia P., Kulkarni J.D., Pai S.A

Im glad I found this forum

Consequently, quality-focused manufacturing remains an important consideration for ongoing laboratory investigations

But the problem here is that the science needed to prove that some patients with Pernicious Anaemia, that is who have a problem absorbing B12 in their stomach need enormous amounts of replacement B12 is simply not there yet

Peptide therapy for weight management is prescribed and supervised by a licensed medical provider, and it is not a substitute for diet, exercise, or medical care